Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-26

Clinical Trial Update: Intravenous Norepinephrine for Orthostatic Hypotension [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating intravenous norepinephrine for orthostatic hypotension has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Norepinephrine (Levophed) (norepinephrine)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Orthostatic Hypertension | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-03-26